Navigation Links
Media Statement: MHA Keystone Center for Patient Safety & Quality OHRP Ruling
Date:2/20/2008

LANSING, Mich., Feb. 20 /PRNewswire-USNewswire/ --

Background: In August 2007 the U.S. Department of Health and Human Services, Office of Human Research Protection (OHRP) expressed the belief that the MHA Keystone Center for Patient Safety & Quality Intensive Care Unit (ICU) collaborative was human subjects research and not quality improvement. As a result, the collaborative required review by the Institutional Review Board (IRB) at each participating hospital.

In light of OHRP's determination, the MHA Keystone Center worked with the participating hospitals to meet the requirements of human subjects research, including IRB review, while at the same time questioning the ruling. On Feb. 14, 2008, the OHRP overturned its previous ruling regarding the ICU collaborative.

The following statement is from Spencer Johnson, president of the Michigan Health & Hospital Association (MHA):

"In light of the recent OHRP ruling, the MHA is delighted to be moving forward with the lifesaving work of the MHA Keystone: ICU collaborative. The final ruling reached by the OHRP falls in step with the MHA's original assertion that the work of the MHA Keystone: ICU collaborative represented quality improvement, as opposed to human subjects research.

"During the past months, the MHA Keystone Center for Patient Safety & Quality and its expert partner, Johns Hopkins University, worked with the OHRP to clarify the definitions of quality improvement and human subjects research and ensure compliance with all state and federal patient safety regulations.

"We believe the oversight role of the OHRP is vital in assuring that patients' needs are served. At the same time, we are hopeful that this experience will create an environment for dialogue to better support quality improvement activities without overly burdensome research oversight.

"The MHA Keystone Center is fully committed to improving quality patient care in all Michigan hospitals and is proud of its role as a pioneer in patient safety and quality improvement. We look forward to the continued success of this collaborative and our other nation-leading patient safety advances."


'/>"/>
SOURCE Michigan Health & Hospital Association
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
2. Clinical Data Presented on OrthoGlide(R) Medial Knee Implant
3. The OrthoGlide(TM) Medial Knee Implant Continues to be Accepted as an Alternative to Total Knee Replacement
4. Data Presented at the American Heart Association Scientific Sessions 2007 Demonstrated Increased HDL with ACTOS(R) (pioglitazone HCl) Slowed the Progression of Carotid Intima-Media Thickness in Patients with Type 2 Diabetes
5. Superbug Outbreak Calls for Immediate Increased Attention on Infection Control
6. Hospital to Hold MRSA Briefing for Media and Community Leaders
7. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
8. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
9. Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data for Trodusquemine (MSI-1436) at Keystone Symposia
10. Diagnostic Center for Disease: Prostate Biopsy Spreads Prostate Cancer Cells
11. QIAGEN and Center for Molecular Medicine Create Research Collaboration for Molecular Diagnostic Markers for Breast Cancer, Other Womens Health Issues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... Research and Markets has announced the addition of the ... offering. ... is very strong with a total of 97 drug candidates. Pharma giant ... are involved in the development of the IPF therapeutics. The IPF pipeline ... stage, 15 are in Phase II stage, 12 are in Phase I ...
(Date:3/24/2017)... , March 24, 2017 A ReportsnReports.com report ... been growing rapidly as the global sales of Adcetris and Kadcyla ... in the antibody drug conjugates market is driven by large number ... and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 ...
(Date:3/24/2017)... 2017 Today Stock-Callers.com have issued research ... Neovasc Inc. (NASDAQ: NVCN), Hologic Inc. (NASDAQ: HOLX), Edwards Lifesciences ... SSH ). These companies are part of the Healthcare sector, ... March 23 rd , 2017, with the NYSE Health Care ... care companies in the S&P 500 were down about 0.4% ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... Judy Buchanan, co-owner of ... Frederick, MD. Judy says, “I am passionate about sharing Reiki as a holistic, ... difficult and challenging time.” , A Certified Medical Reiki™ Master trained by Raven ...
(Date:3/24/2017)... ... ... “End Time GPS”: a dauntless and enlightened study of the second-coming ... the creation of published author, Wesley Gerboth, a World War II veteran, with a ... Now, at age ninety-one, he shares the Wisdom God bestowed upon him in this ...
(Date:3/24/2017)... ... March 24, 2017 , ... ... inspiring stories about real people of God in congregations across the United States. ... a Presbyterian minister ordained in 1964 who has served congregations in seven states ...
(Date:3/23/2017)... ... March 23, 2017 , ... In 2016 the World ... that there could be four million Zika-related cases in the Americas within the next ... of US cases reported per year skyrocketing to an estimated 329,000. Yet, Zika, Lyme ...
(Date:3/23/2017)... ... March 23, 2017 , ... The physicians of KSF Orthopaedic Center PA are ... The new location is located at 2255 E. Mossy Oaks Rd., Suite 440, Spring, ... location will provide patients living in the north Houston area (The Woodlands, Conroe, Magnolia, ...
Breaking Medicine News(10 mins):